Retatrutide is a triple-agonist peptide that targets GLP-1, GIP, and glucagon receptors. It is widely used in research to study metabolic regulation, hormone receptor interactions, and complex endocrine pathways. Retatrutide is intended strictly for research use only and is not approved for human or animal consumption.